RCS - Eco Animal Health Gp - Investor Presentation covering Interim Results

ECO Animal HealthAnnouncement

22/11/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221122:nRSV1231Ha&default-theme=true

RNS Number : 1231H  Eco Animal Health Group PLC  22 November 2022

ECO Animal Health Group plc

(''ECO" or the "Group") (AIM: EAH)

 

Investor Presentation covering Interim Results

ECO Animal Health Group plc, a leader in the development, registration and
marketing of pharmaceutical products for global animal health markets, is
pleased to announce that David Hallas, CEO, and Christopher Wilks, CFO, will
be conducting a live presentation covering the Group's interim results for the
period ended 30 September 2022.

The online presentation will take place on Monday 28 November at 10.00
am UK time. This event is open to all existing and potential shareholders
and registration is free. Questions can be submitted during the presentation
and will be addressed at the end of it.

 

To register for the event, please click here
(https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-resultspresentation-28nov2022)

 

A video recording of the presentation will be available shortly
afterwards here
(https://www.equitydevelopment.co.uk/research/tag/eco-animal-health)

 

Contacts:

 

 

 ECO Animal Health Group plc                                    020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)

 IFC Advisory                                                   020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Mark Taylor

 George Tzimas

 Investec (Joint Broker)                                        020 7597 5970

 Gary Clarence

 Daniel Adams

 Carlo Spingardi

 Peel Hunt LLP (Joint Broker)                                   020 7418 8900

 Dr Christopher Golden

 James Steel

 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans

 

About ECO Animal Health

 

ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABRBDBISDDGDB